首页> 外文期刊>Hand >Hand Corticosteroid Injections in Patients on “Blood Thinners”
【24h】

Hand Corticosteroid Injections in Patients on “Blood Thinners”

机译:手中的皮质类固醇注射患者“血液稀释剂”

获取原文
           

摘要

Background: Our study aims to identify any influence that anticoagulation and antiplatelet (“blood thinner”) medications have on hand and wrist corticosteroid injection complication rates. Methods: This retrospective chart review looked at patients between the ages of 18 and 89 years who received corticosteroid injections in the hand or wrist between 2013 and 2017, noting anticoagulation and antiplatelet use, demographics, injection placement, and surgical intervention. Results: Only 152 (20.9%) of the 726 diagnoses that were treated needed eventual surgical intervention. There were 12 overall reported complications after 1473 injections (0.8%). There were 6 complications after 433 injections (1.6%) placed in patients on blood thinners and 6 complications after 1040 injections (0.6%) placed in patients not on blood thinners. Conclusions: With the complication rate of corticosteroid injections being so low, even in patients taking “blood thinners,” the fear of adverse reactions should not preclude a physician from using this treatment modality to prevent surgical intervention.
机译:背景:我们的研究旨在识别抗凝和抗血小板(“血液稀释剂”)药物的任何影响以及手腕皮质类固醇注射复杂性率。方法:此回顾性图表审查观察了2013年和2017年在2013年和2017年之间的手或手腕中的18和89岁之间的患者,注意到抗凝和抗血小板使用,人口统计,注射放置和外科手术。结果:诊断只有152(20.9%),需要治疗最终的手术干预。 1473次注射后,共有12个报告的并发症(0.8%)。在血液稀释剂的患者患者中患者(1.6%)后有6个并发症,在1040次注射后的6个并发症(0.6%),患者稀释于血液稀释剂。结论:随着皮质类固醇注射的并发症率为如此之低,即使在服用“血液稀释的患者”的患者中也不应排除医生使用这种治疗方式来防止外科手术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号